Interaction and molecular dynamics simulation study of Osimertinib (AstraZeneca 9291) anticancer drug with the EGFR kinase domain in native protein and mutated L844V and C797S

2019 ◽  
Vol 120 (8) ◽  
pp. 13046-13055 ◽  
Author(s):  
Vahideh Assadollahi ◽  
Behnam Rashidieh ◽  
Masoud Alasvand ◽  
Alina Abdolahi ◽  
J. Alejandro Lopez
Sign in / Sign up

Export Citation Format

Share Document